Search research articles
Contact Us
Filters
Showing results (371-380 of 724) with videos related to
Page
of 73
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 19, 2000
Flavopiridol, a novel cyclin-dependent kinase inhibitor, in metastatic renal cancer: a University of Chicago Phase II Consortium study
W M Stadler, N J Vogelzang, R Amato, et al.
Annals of Hematology
|
February 1, 1994
In patients with BCR-ABL-positive ALL in CR peripheral blood contains less residual disease than bone marrow: implications for autologous BMT
H Martin, J Atta, J Bruecher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 28, 2002
A phase II trial of weekly intravenous gemcitabine and cisplatin with continuous infusion fluorouracil in patients with metastatic renal cell carcinoma
C M George, N J Vogelzang, B I Rini, et al.
Annals of the New York Academy of Sciences
|
September 6, 2007
Designed ankyrin repeat proteins as anti-idiotypic-binding molecules
Monique Vogel, Elsbeth Keller-Gautschi, Michael J Baumann, et al.
BMJ Open
|
December 18, 2019
Implementation of prevention of mother-to-child transmission (PMTCT) in South Africa: outcomes from a population-based birth cohort study in Paarl, Western Cape
Jennifer Pellowski, Catherine Wedderburn, Jacob A M Stadler, et al.
Plos One
|
April 30, 2013
Designed ankyrin repeat proteins: a new approach to mimic complex antigens for diagnostic purposes?
Stefanie Hausammann, Monique Vogel, Johanna A Kremer Hovinga, et al.
Critical Reviews in Oncology/Hematology
|
July 27, 2010
Cognitive effects of androgen deprivation therapy in an older cohort of men with prostate cancer
Supriya Gupta Mohile, Maureen Lacy, Miriam Rodin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 19, 2004
Depletion of normal B cells with rituximab as an adjunct to IL-2 therapy for renal cell carcinoma and melanoma
M Aklilu, W M Stadler, M Markiewicz, et al.
International Archives of Allergy and Applied Immunology
|
January 1, 1991
IgG anti-IgE autoantibodies in immunoregulation
B M Stadler, Q Gang, M Vogel, et al.
Cancer Chemotherapy and Pharmacology
|
June 15, 2000
Development of a schedule-dependent population pharmacodynamic model for rhizoxin without quantitation of plasma concentrations
B C Goh, G F Fleming, L Janisch, et al.
Page
of 73
Search research articles
Search
Showing results (371-380 of 724) with videos related to
Sort By:
Page
of 73
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 19, 2000
Flavopiridol, a novel cyclin-dependent kinase inhibitor, in metastatic renal cancer: a University of Chicago Phase II Consortium study
W M Stadler, N J Vogelzang, R Amato, et al.
Annals of Hematology
|
February 1, 1994
In patients with BCR-ABL-positive ALL in CR peripheral blood contains less residual disease than bone marrow: implications for autologous BMT
H Martin, J Atta, J Bruecher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 28, 2002
A phase II trial of weekly intravenous gemcitabine and cisplatin with continuous infusion fluorouracil in patients with metastatic renal cell carcinoma
C M George, N J Vogelzang, B I Rini, et al.
Annals of the New York Academy of Sciences
|
September 6, 2007
Designed ankyrin repeat proteins as anti-idiotypic-binding molecules
Monique Vogel, Elsbeth Keller-Gautschi, Michael J Baumann, et al.
BMJ Open
|
December 18, 2019
Implementation of prevention of mother-to-child transmission (PMTCT) in South Africa: outcomes from a population-based birth cohort study in Paarl, Western Cape
Jennifer Pellowski, Catherine Wedderburn, Jacob A M Stadler, et al.
Plos One
|
April 30, 2013
Designed ankyrin repeat proteins: a new approach to mimic complex antigens for diagnostic purposes?
Stefanie Hausammann, Monique Vogel, Johanna A Kremer Hovinga, et al.
Critical Reviews in Oncology/Hematology
|
July 27, 2010
Cognitive effects of androgen deprivation therapy in an older cohort of men with prostate cancer
Supriya Gupta Mohile, Maureen Lacy, Miriam Rodin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 19, 2004
Depletion of normal B cells with rituximab as an adjunct to IL-2 therapy for renal cell carcinoma and melanoma
M Aklilu, W M Stadler, M Markiewicz, et al.
International Archives of Allergy and Applied Immunology
|
January 1, 1991
IgG anti-IgE autoantibodies in immunoregulation
B M Stadler, Q Gang, M Vogel, et al.
Cancer Chemotherapy and Pharmacology
|
June 15, 2000
Development of a schedule-dependent population pharmacodynamic model for rhizoxin without quantitation of plasma concentrations
B C Goh, G F Fleming, L Janisch, et al.
Page
of 73